High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study
Top Cited Papers
- 28 July 2016
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 48 (5), 1442-1452
- https://doi.org/10.1183/13993003.00129-2016
Abstract
Evidence suggests that lung injury, inflammation and extracellular matrix remodelling precede lung fibrosis in interstitial lung disease (ILD). We examined whether a quantitative measure of increased lung attenuation on computed tomography (CT) detects lung injury, inflammation and extracellular matrix remodelling in community-dwelling adults sampled without regard to respiratory symptoms or smoking. We measured high attenuation areas (HAA; percentage of lung voxels between −600 and −250 Hounsfield Units) on cardiac CT scans of adults enrolled in the Multi-Ethnic Study of Atherosclerosis. HAA was associated with higher serum matrix metalloproteinase-7 (mean adjusted difference 6.3% per HAA doubling, 95% CI 1.3–11.5), higher interleukin-6 (mean adjusted difference 8.8%, 95% CI 4.8–13.0), lower forced vital capacity (FVC) (mean adjusted difference −82 mL, 95% CI −119–−44), lower 6-min walk distance (mean adjusted difference −40 m, 95% CI −1–−80), higher odds of interstitial lung abnormalities at 9.5 years (adjusted OR 1.95, 95% CI 1.43–2.65), and higher all cause-mortality rate over 12.2 years (HR 1.58, 95% CI 1.39–1.79). High attenuation areas are associated with biomarkers of inflammation and extracellular matrix remodelling, reduced lung function, interstitial lung abnormalities, and a higher risk of death among community-dwelling adults. Increased lung attenuation on CT may identify subclinical lung injury and inflammation in community-dwelling adultshttp://ow.ly/97k3300tvKXKeywords
Funding Information
- National Center for Research Resources (UL1-RR-025005, UL1-TR-000040)
- National Heart, Lung, and Blood Institute (N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, R01 HL077612, R01 HL103676, R01 HL114626, R01-HL083091, RC1-100543, T32 HL105323)
- Pulmonary Fibrosis Foundation
This publication has 56 references indexed in Scilit:
- Subclinical Interstitial Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Interstitial Lung Abnormalities and Reduced Exercise CapacityAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Idiopathic Pulmonary Fibrosis: A Disorder of Epithelial Cell DysfunctionThe Lancet Healthy Longevity, 2011
- Lung Volumes and Emphysema in Smokers with Interstitial Lung AbnormalitiesNew England Journal of Medicine, 2011
- Association Between Combined Interleukin-6 and C-Reactive Protein Levels and Pulmonary Function in Older Women: Results from the Women's Health and Aging Studies I and IIJournal of the American Geriatrics Society, 2011
- Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular FillingNew England Journal of Medicine, 2010
- Identification of Early Interstitial Lung Disease in Smokers from the COPDGene StudyAcademic Radiology, 2009
- Reproducibility and Validity of Lung Density Measures from Cardiac CT Scans—The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study1Academic Radiology, 2009
- Chronic airflow obstruction and markers of systemic inflammation: Results from the BOLD study in IcelandRespiratory Medicine, 2009